Search Results - "Imura, Y"

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system by Tokunaga, Mikiko, Saito, Kazuyoshi, Kawabata, Daisuke, Imura, Yoshitaka, Fujii, Takao, Nakayamada, Shingo, Tsujimura, Shizuyo, Nawata, Masao, Iwata, Shigeru, Azuma, Taeko, Mimori, Tsuneyo, Tanaka, Yoshiya

“…Aim: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious treatment-resistant phenotype of systemic lupus erythematosus. A standard treatment for…”
Get full text

Cytological and biochemical analysis of COF1, an Arabidopsis mutant of an ABC transporter gene by Ukitsu, H.(Yokohama City Univ. (Japan)), Kuromori, T, Toyooka, K, Goto, Y, Matsuoka, K, Sakuradani, E, Shimizu, S, Kamiya, A, Imura, Y, Yuguchi, M, Wada, T, Hirayama, T, Shinozaki, K

“…In transposon-tagged lines of Arabidopsis we found two new mutants, cof1-1 and cof1-2 (cuticular defect and organ fusion), that show the phenotype of wilting…”
Get full text

TAK-536, a New AT1 Receptor Blocker, Improves Glucose Intolerance and Adipocyte Differentiation by Iwai, Masaru, Chen, Rui, Imura, Yoshimi, Horiuchi, Masatsugu

“…Background: The effects of a new AT1 receptor blocker (ARB), TAK-536, on insulin resistance were explored using type 2 diabetic KK-Ay mice and compared with…”
Get full text

Analysis of artifact with X-ray CT using energy band by photon counting CdTe detector by Matsumoto, G., Imura, Y., Morii, H., Miyake, A., Aoki, T.

“…This report analyzes the imaging errors in what are called “artifacts” by a CdTe detector with the energy differentiation ability using the photon counting…”
Get full text

Unified approach for open-loop optimal control by Imura, Y., Naidu, D. S.

“…We develop a unified approach for the necessary conditions for optimization of open‐loop control systems, starting from the basic principles of calculus of…”
Get full text

Negative pressure booth with HEPA filter reduces the risk of airborne infection associated with transoesophageal echocardiography by Machino, T, Watabe, K, Imura, Y, Kawamatsu, N, Sato, K, Yamamoto, M, Ishizu, T, Kawakami, Y

“…Abstract Background The pandemic of coronavirus infection 2019 has persisted, despite reductions in disease severity and deaths. Transoesophageal…”
Get full text

Unified approach for Euler-Lagrange equation arising in calculus of variations by Naidu, D. S., Imura, Y.

“…We address the development of a unified approach for the necessary conditions for optimization of a functional arising in calculus of variations. In…”
Get full text

Irradiance-dependence and translation of the I-V characteristics of crystalline silicon solar cells by Hishikawa, Y., Imura, Y., Oshiro, T.

“…The current-voltage characteristics I/sub out/(V) of crystalline silicon (c-Si) solar cells are experimentally investigated at various irradiance E. Its…”
Get full text

Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents by Terashita, Z, Kawamura, M, Takatani, M, Tsushima, S, Imura, Y, Nishikawa, K

“…Pharmacological profiles of a novel specific platelet activating factor (PAF) antagonist, TCV-309 (3-bromo-5-[N-phenyl-N-[2-[2-…”
Get more information

TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats by Kawamura, M, Terashita, Z, Okuda, H, Imura, Y, Shino, A, Nakao, M, Nishikawa, K

“…Inhibitory effects of TCV-116 [(+-)-1-(cyclohexyloxycarbonyloxy)ethyl2-ethoxy-1-[[2'-(1H- tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate],…”
Get more information

Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model by Imura, Y, Stassen, J M, Collen, D

“…The antithrombotic properties of bolus i.v. injections of heparin, of recombinant hirudin (r-hirudin) or of the synthetic competitive thrombin inhibitor…”
Get more information

CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo by Terashita, Z, Imura, Y, Takatani, M, Tsushima, S, Nishikawa, K

“…2-[N-acetyl-N-(2-methoxy-3-octadecylcarbamoyloxypropoxycarbonyl) aminomethyl]-1-ethylpyridinium chloride (CV-6209) inhibited aggregation of rabbit and human…”
Get more information

Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban by Kawamura, M, Imura, Y, Moriya, N, Kita, S, Fukushi, H, Sugihara, H, Nishikawa, K, Terashita, Z

“…The antithrombotic and bleeding time (BT)-prolonging effects of TAK-029, a novel glycoprotein IIb/IIIa antagonist, were characterized and compared with those…”
Get more information

Future aspects on endocrinology by Imura, Y

Get more information

Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance by Mimori, Tsuneyo, Imura, Yoshitaka, Nakashima, Ran, Yoshifuji, Hajime

“…PURPOSE OF REVIEWIdiopathic inflammatory myopathy is characterized by the production of autoantibodies to various cellular constituents. These autoantibodies…”
Get full text

A42 AUTOIMMUNE MYOSITIS, ANTISYNTHETASE, SCLERODERMA, AND IPAF: Clinical Features And Predictive Factors For Long-Term Follow-Up In Polymyositis/dermatomyositis-Associated Interstitial Lung Diseases by Fujisawa, T, Hozumi, H, Kono, M, Enomoto, N, Nakamura, Y, Inui, N, Nakashima, R, Imura, Y, Mimori, T, Suda, T

Get full text

Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation by Kawamura, M, Terashita, Z, Imura, Y, Shino, A, Nishikawa, K

“…The possible involvement of platelet activating factor (PAF) in the pathogenesis of endotoxin-induced disseminated intravascular coagulation (DIC) was…”
Get more information

The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage by Imura, Y, Terashita, Z, Nishikawa, K

“…To clarify the role of thromboxane (TX) A2 in arterial thrombus formation, we examined the antithrombotic effects of both a TXA2 synthetase inhibitor (CV-4151)…”
Get more information

A lethal role of platelet activating factor in anaphylactic shock in mice by Terashita, Z, Imura, Y, Shino, A, Nishikawa, K

“…The lethal role of platelet activating factor (PAF) in anaphylactic shock was examined in mice, using the specific PAF antagonist, CV-3988. CV-3988 (0.3-3…”
Get more information

Thrombolytic and Pharmacokinetic Properties of an Immunoconjugate of Single-Chain Urokinase-Type Plasminogen Activator (u-PA) and a Bispecific Monoclonal Antibody Against Fibrin and Against u-PA in Baboons by Imura, Y., Stassen, J.M., Kurokawa, T., Iwasa, S., Lijnen, H.R., Collen, D.

“…Targeting of plasminogen activators to the fibrin component of a thrombus with the use of monoclonal antibodies (MA) directed against human fibrin may enhance…”
Get full text